# Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

> **NCT01456611** · PHASE3 · COMPLETED · sponsor: **Anchen Pharmaceuticals, Inc** · enrollment: 749 (actual)

## Conditions studied

- Osteo Arthritis of the Knee

## Interventions

- **DRUG:** Diclofenac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01456611
- **Lead sponsor:** Anchen Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 749 (ACTUAL)
- **Last updated:** 2012-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456611, "Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01456611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*